Notification received under Article 69 of the Act on Public Offering, Conditions Governing the Introduction of Financial Instruments to Organised Trading, and Public Companies

Date: 12 February 2025

Subject: Notification received under Article 69 of the Act on Public Offering, Conditions Governing the Introduction of Financial Instruments to Organised Trading, and Public Companies

Legal basis: Article 70.1 of the Act on Public Offering, Conditions Governing the Introduction of Financial Instruments to Organised Trading, and Public Companies of 29 July 2005

Text of the report:
Acting in performance of the obligation arising under Article 70.1 of the Act on Public Offering, Conditions Governing the Introduction of Financial Instruments to Organised Trading, and Public Companies of 29 July 2005 (the “Public Offering Act”), the Management Board of Diagnostyka S.A. of Kraków (the “Company”) announces that on 11 February 2025 the Company received a notification from LX Beta S.à r.l. under Article 69.1.2 of the Public Offering Act regarding a change in its equity and voting interest in the Company.

The notification is attached as an appendix hereto.

For the Company:
Paweł Chytła – Vice President of the Management Board
Jaromir Pelczarski – Vice President of the Management Board